COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,160 Articles (22,703 medRxiv, 8,457 bioRxiv)

Most recent first Previous |  Page 284: Articles 2831-2840  | Next

In Silico Therapeutic Intervention on Cytokine Storm in COVID-19
Bakshi, A., Gangopadhyay, K., Basak, S., Chakrabarti, A., Dasgupta, A., De, R. K.
10.1101/2023.12.05.570280 — Posted: 2023-12-07
Overall health effects of mRNA COVID-19 vaccines in children and adolescents: a systematic review and meta-analysis
Hoffmann, S. S., Nielsen, S., Thysen, S. M., Duriseti, R., Benn, C. S.
10.1101/2023.12.07.23298573 — Posted: 2023-12-07
Algorithm for selecting potential SARS-CoV-2 dominant variants based on POS-NT frequency
Kang, E., Ahn, T., Park, T.
10.1101/2023.12.05.570216 — Posted: 2023-12-07
Feasibility characteristics of wrist-worn fitness trackers in health status monitoring for post-COVID patients in remote and rural areas
Wiebe, M., Mackay, M., Krishnan, R., Tian, J., Larsson, J., Modanloo, S., Job Mcintosh, C., Sztym, M., Elton-Smith, G., Rose, A., Ho, C., Greenshaw, A., Cao, B., Chan, A., Hayward, J.
10.1101/2023.12.05.23299499 — Posted: 2023-12-06
The role of veterinary diagnostic laboratories during COVID-19 response in the United States
Clements, N., Diel, D. G., Elvinger, F., Koretzky, G., Siler, J., Warnick, L. D.
10.1101/2023.12.05.23299493 — Posted: 2023-12-06
Immune profiling of COVID-19 vaccine responses in people with multiple sclerosis on B cell-depleting therapy
Perkins, G. B., Hope, C. M., Chai, C. S., Tunbridge, M. J., Sterling, S., Webb, K., Yap, J., Yeow, A. E. L., Masavuli, M. G., Kireta, S., Zuiani, J. D., Akerman, A., Aggarwal, A., Milogiannakis, V., Roberts, M. B., Willson, W., Hurtado, P. R., Turville, S. G., Grubor-Bauk, B., Barry, S. C., Coates, P. T., Ravindran, J., Hissaria, P.
10.1101/2023.12.04.23299409 — Posted: 2023-12-05
COVID-19 vaccination uptake among healthcare workers in Ghana: A comprehensive analysis of knowledge, attitude, perceived vaccine effectiveness, and health belief model constructs
Mbele, W., Dako-Gyeke, P., Frans, A. N.
10.1101/2023.12.05.23299475 — Posted: 2023-12-05
Influenza Mortality as an Indicator of the Efficacy of COVID-Related, Non-pharmaceutical Interventions to Reduce the Spread of Respiratory Infections
Morris, R. D.
10.1101/2023.11.30.23299157 — Posted: 2023-12-05
SARS-CoV-2 Infection is Associated with an Increase in New Diagnoses of Schizophrenia Spectrum and Psychotic Disorder: A Study Using the US National COVID Cohort Collaborative (N3C)
Rahman, A., Russell, M., Zheng, W., Eckrich, D., Ahmed, I., on behalf of the N3C Consortium
10.1101/2023.12.05.23299473 — Posted: 2023-12-05
Supporting young people through the COVID-19 pandemic and beyond: A multi-site qualitative longitudinal study
Whyte, M., Nicol, E., Hawke, L., Wuerth, K., Quinlan-Davidson, M., O'Reilly, A., Duffy, J., Mathias, S., Henderson, J., Barbic, S. P.
10.1101/2023.12.05.23299469 — Posted: 2023-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).